Zaven Orfalian, Sigma-Tau Pharmaceuticals, Pomezia, Italy
March 31st, 2025: Plaintiffs Push Back on Ozempic Dismissal Motion, Accuse Drug Makers of Downplaying GI Risks Plaintiffs in the GLP-1 drug litigationincluding claims involving Ozempic, Wegovy, and Mounjarohave asked a federal judge to reject dismissal efforts by Novo Nordisk and Eli Lilly
Scientific Evidence and Effectiveness in Orthopaedic Use Scientific research increasingly supports the effectiveness of Ozone Infusion Therapy across various orthopaedic applications
Conclusion arGLP-1 are effective and safe for managing IWL or WR after BS, leading to significant weight loss, comorbidity improvement, and sustained %TWL
Then the amino group of glycine participates in a nucleophilic attack, displacing the phosphate group and forming GSH